Moderna Will Submit For Emergency Use Authorization with FDA
November 30, 2020 at 08:25 AM EST
Moderna announced that it will submit for an Emergency Use Authorization with the U.S. FDA and an application for Conditional Marketing Authorization with the European Medicines Agency for its Covid-19 vaccine mRNA-1273.